ArticleJournal of experimental & clinical cancer research : CR2023

The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma.

Mei Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.